metformin has been researched along with Cross Infection in 1 studies
Metformin: A biguanide hypoglycemic agent used in the treatment of non-insulin-dependent diabetes mellitus not responding to dietary modification. Metformin improves glycemic control by improving insulin sensitivity and decreasing intestinal absorption of glucose. (From Martindale, The Extra Pharmacopoeia, 30th ed, p289)
metformin : A member of the class of guanidines that is biguanide the carrying two methyl substituents at position 1.
Cross Infection: Any infection which a patient contracts in a health-care institution.
Excerpt | Relevance | Reference |
---|---|---|
"131 949 patients with type 2 diabetes who initiated pharmacotherapy with a GLD between 2005 and 2012." | 1.43 | Metformin and other glucose-lowering drug initiation and rates of community-based antibiotic use and hospital-treated infections in patients with type 2 diabetes: a Danish nationwide population-based cohort study. ( Mor, A; Petersen, I; Sørensen, HT; Thomsen, RW, 2016) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Mor, A | 1 |
Petersen, I | 1 |
Sørensen, HT | 1 |
Thomsen, RW | 1 |
1 other study available for metformin and Cross Infection
Article | Year |
---|---|
Metformin and other glucose-lowering drug initiation and rates of community-based antibiotic use and hospital-treated infections in patients with type 2 diabetes: a Danish nationwide population-based cohort study.
Topics: Adult; Aged; Anti-Bacterial Agents; Cohort Studies; Community Health Services; Cross Infection; Denm | 2016 |